Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06152822
What this trial is testing

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Who this might be right for
Breast Cancer With Brain Metastases
Tongji Hospital 30
Not applicableActive Not RecruitingNCT05215769
What this trial is testing

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Carcinoma+5 more
Ohio State University Comprehensive Cancer Center 243
Not applicableStudy completedNCT07211451
What this trial is testing

Axillary Nodal Burden in HER2+ and TNBC

Who this might be right for
Breast Cancer
Gangnam Severance Hospital 1,571
Testing effectiveness (Phase 2)Study completedNCT04150731
What this trial is testing

16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer

Who this might be right for
Breast Cancer
University of Aarhus 8
Not applicableStudy completedNCT01880645
What this trial is testing

Selective Image Guided Resection of Axillary Lymph Nodes

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 17
Not applicableEnded earlyNCT03970967
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Who this might be right for
Breast CarcinomaMetastatic Breast CancerInvasive Breast Cancer+1 more
Alpha Tau Medical LTD. 1
Large-scale testing (Phase 3)Active Not RecruitingNCT03734029
What this trial is testing

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

Who this might be right for
Breast Cancer
Daiichi Sankyo 557
Not applicableStudy completedNCT01811264
What this trial is testing

Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University 150
Not applicableLooking for participantsNCT05573893
What this trial is testing

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Who this might be right for
Breast NeoplasmsBreast CancerNeoplasm Metastasis
AstraZeneca 800
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Testing effectiveness (Phase 2)UnknownNCT02602938
What this trial is testing

Aspirin on CTCs of Advanced Breast and Colorectal Cancer

Who this might be right for
Epithelial-Mesenchymal TransitionCirculating Tumor Cells
Zhejiang Provincial People's Hospital 40
Testing effectiveness (Phase 2)UnknownNCT03147963
What this trial is testing

Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00319748
What this trial is testing

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+1 more
Masonic Cancer Center, University of Minnesota 15
Not applicableUnknownNCT03572998
What this trial is testing

Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment

Who this might be right for
Secondary Lymphedema
University of Aarhus 28
Testing effectiveness (Phase 2)Study completedNCT00046514
What this trial is testing

ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsMetastases, Neoplasm
Celgene Corporation 100
Testing effectiveness (Phase 2)Ended earlyNCT00638963
What this trial is testing

Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)

Who this might be right for
Breast NeoplasmBrain NeoplasmSecond Neoplasm
Merck Sharp & Dohme LLC 6
Large-scale testing (Phase 3)Study completedNCT00327769
What this trial is testing

Faslodex Advanced Breast Cancer Local Chinese Study

Who this might be right for
Advanced Breast Cancer
AstraZeneca 234
Not applicableWithdrawnNCT01939483
What this trial is testing

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Who this might be right for
Central Nervous System MetastasesMale Breast CancerRecurrent Breast Cancer+1 more
University of California, Irvine
Testing effectiveness (Phase 2)Study completedNCT02260531
What this trial is testing

Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases

Who this might be right for
Breast CancerBrain Tumor - Metastatic
Dana-Farber Cancer Institute 36
Not applicableUnknownNCT03979339
What this trial is testing

Feasibility of a New Technology for Isolating Circulating Tumour Cells

Who this might be right for
HER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more
Centre Oscar Lambret 76
Next Page